Moderna, Inc. (NASDAQ:MRNA – Get Free Report) Director Noubar Afeyan sold 20,000 shares of the stock in a transaction dated Wednesday, May 29th. The stock was sold at an average price of $145.08, for a total transaction of $2,901,600.00. Following the completion of the sale, the director now directly owns 1,961,931 shares in the company, […]